Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3017]

Molecular targeting in cancer and the impact on personalised medicine

Prof Christian Dittrich - Ludwig Boltzmann Institute for Applied Cancer...

Molecular targeting in cancer and the impact on personalised medicine ( Prof Christian Dittrich - Ludwig Boltzmann Institute for Applied Cancer Research, Vienna, Austria )

Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for...

Dr Sandra Swain - Washington Cancer Institute, Washington, USA

Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer ( Dr Sandra Swain - Washington Cancer Institute, Washington, USA )

Cediranib and chemo combo improves PFS for metastatic cervical cancer

Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK

Cediranib and chemo combo improves PFS for metastatic cervical cancer ( Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK )

Phase III trial results raise questions about the future of lung cancer...

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium

Phase III trial results raise questions about the future of lung cancer vaccination ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )

Little benefit for gefitinib-resistant lung cancer when continuing the drug...

Dr Tony Mok - The Chinese University of Hong Kong, Shatin, China

Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemotherapy ( Dr Tony Mok - The Chinese University of Hong Kong, Shatin, China )

Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for...

Dr Sandra Swain - Washington Cancer Institute, Washington, USA

Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer ( Dr Sandra Swain - Washington Cancer Institute, Washington, USA )

Adding cediranib to chemo improves PFS for metastatic cervical cancer

Dr Paul Symonds - University Hospital of Leicester, Leicester, UK

Adding cediranib to chemo improves PFS for metastatic cervical cancer ( Dr Paul Symonds - University Hospital of Leicester, Leicester, UK )

Helping cancer patients make sense of risk

Prof Rocio Garcia-Retamero - University of Granada, Granada, Spain

Helping cancer patients make sense of risk ( Prof Rocio Garcia-Retamero - University of Granada, Granada, Spain )

Reducing nausea and vomiting associated with cisplatin-based chemotherapy with...

Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South...

Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant ( Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa )

Rare cancers and the difficulties in making clinical decisions

Dr Paolo Casali - National Tumour Institute, Milan, Italy

Rare cancers and the difficulties in making clinical decisions ( Dr Paolo Casali - National Tumour Institute, Milan, Italy )

Anamorelin improves appetite and body mass in non-small cell lung cancer with...

Dr David Currow - Flinders University, Adelaide, Australia

Anamorelin improves appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia ( Dr David Currow - Flinders University, Adelaide, Australia )

Rolapitant reduces nausea and vomiting associated with cisplatin-based...

Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South...

Rolapitant reduces nausea and vomiting associated with cisplatin-based chemotherapy ( Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa )

More from ecancer